MJA
MJA

Chronic fatigue syndrome

Med J Aust 2002; 176 (9): 17-55.

Dr Robert Loblay, PhD, FRACP, Immunologist, Department of Medicine, University of Sydney (Convenor); Royal Australasian College of Physicians.

Please login with your free MJA account to view this article in full

  • Victoria Toulkidis


Correspondence: 

  • 1. Loblay RH, for the Clinical and Laboratory Practices Committee, Australasian Society of Clinical Immunology and Allergy. Diagnosis and management of chronic fatigue syndrome. R Australas Coll Physicians Fellowship Affairs 1994; 13: 27-31.
  • 2. National Health and Medical Research Council. Guidelines for the development and implementation of clinical practice guidelines. Canberra: NHMRC, Oct 1995.
  • 3. Ellis CT. A compilation of submissions made by people with chronic fatigue syndrome, and others to the Royal Australasian College of Physicians for the Investigation of Chronic Fatigue and Management of Chronic Fatigue Syndrome Clinical Practice Guidelines 1997 (unpublished).
  • 4. Ellis CT. A CFS Health Consumer Perspective 1997 (in process of publication). Available at <http://www.masmith.inspired.net.au/aus_info/gdlines/consumer.htm>.
  • 5. Osler W. Books and men. Boston Med Surg J 1901; 17 Jan.
  • 6. Fukuda K, Straus SE, Hickie I, et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Sydnrome Study Group. Ann Intern Med 1994; 121: 953-959.
  • 7. Kroenke K, Wood DR, Mangelsdorff D, et al. Chronic fatigue in primary care: prevalence, patient characteristics, and outcome. JAMA 1988; 260: 929-934.
  • 8. David A, Pelosi A, McDonald E, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ 1990; 301: 1199-1202.
  • 9. Cathebras PJ, Robbins JM, Kirmayer LJ, Hayton BC. Fatigue in primary care: prevalence, psychiatric comorbidity, illness behaviour, and outcome. J Gen Intern Med 1992; 7: 276-286.
  • 10. Katerndahl DA. Differentiation of physical and psychological fatigue. Fam Pract Res J 1993; 13: 81-91.
  • 11. Walker EA, Katon WJ, Jemelka RP. Psychiatric disorders and medical care utilization among people in the general population who report fatigue. J Gen Intern Med 1993; 23: 987-998.
  • 12. Fuhrer R, Wessely S. The epidemiology of fatigue and depression: a French primary-care study. Psychol Med 1995; 25: 895-905.
  • 13. Hickie IB, Hooker AW, Hadzi-Pavlovic D, et al. Fatigue in selected primary care settings: sociodemographic and psychiatric correlates. Med J Aust 1996; 164: 585-588.
  • 14. Lewis G, Wessely S. The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health 1992; 46: 92-97.
  • 15. Pawlikowska T, Chalder T, Hirsch SR, et al. Population based study of fatigue and psychological distress. BMJ 1994; 308: 763-766.
  • 16. Hickie IB, Lloyd AR, Wakefield D. Chronic fatigue syndrome: current perspectives on evaluation and management. Med J Aust 1995; 163: 314-318.
  • 17. Nisenbaum R, Reyes M, Mawle AC, Reeves WC. Factor analysis of unexplained severe fatigue and interrelated symptoms: overlap with criteria for chronic fatigue syndrome. Am J Epidemiol 1998; 148: 72-77.
  • 18. Wessely S. Chronic fatigue: symptom and syndrome. Ann Intern Med 2001; 134 Suppl: 838-843.
  • 19. Addington AM, Gallo JJ, Ford DE, Eaton WW. Epidemiology of unexplained fatigue and major depression in the community: the Baltimore ECA follow-up 1981-1994. Psychol Med 2001; 31: 1037-1044.
  • 20. Komaroff AL, Fagioli LR, Doolittle TH, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996; 101: 281-290.
  • 21. Buchwald D, Pearlman T, Umali J, et al. Functional status in patients with chronic fatigue syndrome, other fatiguing illnesses, and healthy individuals. Am J Med 1996; 171: 364-370.
  • 22. Lloyd AR, Pender H. The economic impact of chronic fatigue syndrome. Med J Aust 1992; 157: 599-601.
  • 23. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387-389.
  • 24. Lloyd A, Wakefield D, Dwyer J, Boughton C. What is myalgic encephalomyelitis? Lancet 1988; 1: 1286-1287.
  • 25. Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry 1990; 156: 534-540.
  • 26. Komaroff AL, Buchwald D. Symptoms and signs of chronic fatigue syndrome. Rev Infect Dis 1991; 13 Suppl 1: S8-S11.
  • 27. Komaroff AL, Fagioli LR, Geiger AM, et al. An examination of the working case definition of chronic fatigue syndrome. Am J Med 1996; 100: 56-64.
  • 28. Komaroff AL, Buchwald DS. Chronic fatigue syndrome: an update. Ann Rev Med 1998; 49: 1-13.
  • 29. Levine PH, editor. Recent developments in chronic fatigue syndrome (symposium supplement). Am J Med 1998; 105 (3A).
  • 30. Lloyd AR, Hickie I, Boughton CR, et al. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990; 153: 522-528.
  • 31. Sharpe M, Archard L, Banatvala J, et al. Chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118-121.
  • 32. Schluederberg A, Straus SE, Peterson P, et al. Chronic fatigue syndrome research: definition and medical outcome assessment. Ann Intern Med 1992; 117: 325-331.
  • 33. De Becker P, McGregor N, De Meirleir K. A definition-based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome. J Intern Med 2001; 520: 234-240.
  • 34. Levine PH. Chronic fatigue syndrome comes of age. Am J Med 1998; 105(3A): 2S-6S.
  • 35. Mulrow CD, Ramirez G, Cornell JE, Allsup K. Defining and managing chronic fatigue syndrome. Evidence Report/Technology Assessment No. 42 (Prepared by San Antonio Evidence-based Practice Centre at The University of Texas Health Science Center at San Antonio). AHRQ Publication No. 02-E001. Rockville (MD): Agency for Healthcare Research and Quality; October 2001. <http://www.ahrq.gov/clinic/cfssum.htm>
  • 36. Manu P, Matthews D, Lane TJ. The mental health of patients with a chief complaint of chronic fatigue: a prospective evaluation and follow-up. Arch Intern Med 1988; 148: 2213-2217.
  • 37. Manu P, Lane TJ, Matthews D. The frequency of chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann Intern Med 1988; 109: 554-556.
  • 38. Manu P, Matthews DA, Lane TJ, et al. Depression among patients with a primary complaint of fatigue. J Affect Disord 1989; 17: 165-172.
  • 39. Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome: prevalence in a Pacific Northwest health care system. Ann Intern Med 1995; 123: 81-88.
  • 40. Lawrie SM, Manders DN, Geddes JR, Pelosi AJ. A population-based incidence study of chronic fatigue. Psychol Med 1997; 27: 343-353.
  • 41. Kroenke K. Studying symptoms: sampling and measurement issues. Ann Intern Med 2001; 134 Suppl: 844-853.
  • 42. Aronowitz RA. When do symptoms become a disease? Ann Intern Med 2001; 134 Suppl: 803-808.
  • 43. Jennings D. The confusion between disease and illness in clinical medicine. CMAJ 1986; 135: 865-870.
  • 44. Susser M. Disease, illness, sickness; impairment, disability and handicap. Psychol Med 1990; 20: 471-473.
  • 45. Cassell EJ. The nature of suffering and the goals of medicine. New York: Oxford University Press, 1991.
  • 46. Lloyd AR, Hickie IB, Loblay RH. Illness or disease? The case of chronic fatigue syndrome. Med J Aust 2000; 172: 471-472.
  • 47. A new clinical entity? [editorial] Lancet 1956; 1: 789-790.
  • 48. Wessely S. Old wine in new bottles: neurasthenia and "ME". Psychol Med 1990; 20: 35-53.
  • 49. Hickie I, Hadzi-Pavlovic D, Ricci C. Reviving the diagnosis of neurasthenia. Psychol Med 1997; 27: 989-994.
  • 50. Goldberg, DP, Lecrubier Y. Form and frequency of mental disorders across centres. In: Ustun TB, Sartorius N, editors. Mental illness in general health care: an international study. Chicester: John Wiley and Sons, 1995: 323-334.
  • 51. Buchwald D, Sullivan JL, Komaroff AL. Frequency of "chronic active Epstein-Barr virus infection" in a general medical practice. JAMA 1987; 257: 2303-2307.
  • 52. Bates DW, Schmitt W, Buchwald D, et al. Prevalence of fatigue and chronic fatigue syndrome in a primary care practice. Arch Intern Med 1993; 153: 2759-2765.
  • 53. McDonald E, David AS, Pelosi AJ, Mann AH. Chronic fatigue in primary care attenders. Psychol Med 1993; 23: 987-998.
  • 54. Wessely S, Chalder T, Hirsch S, Wallace P, Wright D. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. Am J Public Health 1997; 87: 1449-1455.
  • 55. Price RK, North CS, Wessely S, Fraser VJ. Estimating the prevalence of chronic fatigue syndrome and associated symptoms in the community. Public Health Rep 1992; 107: 514-522.
  • 56. Gunn WJ, Connell DB, Randall B. Epidemiology of chronic fatigue syndrome: the Centers for Disease Control study. Ciba Foundation Symposium 1993; 173: 83-93.
  • 57. Jason LA, Taylor R, Wagner L, et al. Estimating rates of chronic fatigue syndrome from a community-based sample: a pilot study. Am J Community Psychol 1995; 23: 557-568.
  • 58. Jason LA, Richman JA, Rademaker AW, et al. A community-based study of chronic fatigue syndrome. Arch Intern Med 1999; 159: 2129-2137.
  • 59. Kawakami N, Iwata N, Fujihara S, et al. Prevalence of chronic fatigue syndrome in a community population in Japan. Tohoku J Exp Med 1998; 186: 33-41.
  • 60. Wessely S. The epidemiology of chronic fatigue syndrome. Epidemiol Rev 1995; 17: 139-151.
  • 61. Hickie I, Koschera A, Bennett B, Hadzi-Pavlovic D. Examining the temporal stability of prolonged fatigue: a 12 month longitudinal study. Australasian Society for Psychiatric Research: Annual Scientific Meeting 1996. Program and Abstracts. Melbourne: ASPR, 1996.
  • 62. Jason LA, Jordan KM, Richman JA, et al. A community-based study of prolonged fatigue and chronic fatigue. J Health Psychol 1999; 4: 9-26.
  • 63. Henderson AS. Care-eliciting behavior in man. J Nerv Ment Dis 1974; 159: 172-181.
  • 64. Steele L, Dobbins JG, Fukuda K, et al. The epidemiology of chronic fatigue in San Francisco. Am J Med 1998; 105: 83S-90S.
  • 65. Jason LA, Wagner L, Rosenthal S, et al. Estimating the prevalence of chronic fatigue syndrome among nurses. Am J Med 1998; 105: 91S-93S.
  • 66. Wessely S, Chalder T, Hirsch S, et al. Postinfectious fatigue: prospective cohort study in primary care. Lancet 1995; 345: 1333-1338.
  • 67. White PD, Thomas JM, Amess J, et al. The existence of a fatigue syndrome after glandular fever. Psychol Med 1995; 25: 907-916.
  • 68. Marmion BP, Shannon M, Maddocks I, et al. Protracted debility and fatigue after acute Q fever [letter]. Lancet 1996; 347: 977-978.
  • 69. Eltumi M, Mathieson DM, Brueton MJ, Kovar IZ. Protracted fatigue and debility after acute Q fever [letter]. Lancet 1996; 347: 978-979.
  • 70. Selden SM, Cameron AS. Changing epidemiology of Ross River virus disease in South Australia. Med J Aust 1996; 165: 313-317.
  • 71. Hickie I, Lloyd A, Wakefield D, Ricci C. Is there a postinfection fatigue syndrome? Aust Fam Physician 1996; 25: 1847-1852.
  • 72. Goldenberg DL. Fibromyalgia and its relation to chronic fatigue syndrome, viral illness and immune abnormalities. J Rheumatol 1989; 16 Suppl 19: S91-S93.
  • 73. Goldenberg DL. Fibromyalgia, chronic fatigue syndrome, and myofascial pain [review]. Curr Opin Rheumatol 1996; 8: 113-123.
  • 74. Wessely S, Powell R. Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989; 52: 940-948.
  • 75. Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 1990; 33: 381-387.
  • 76. Kirmayer LJ, Robbins JM. Functional somatic syndromes. In: Kirmayer LJ, Robbins JM, editors. Current concepts of somatization: research and clinical perspectives. Washington, DC: American Psychiatric Press, 1991: 79-106.
  • 77. Moldofsky H. Fibromyalgia, sleep disorder and chronic fatigue syndrome. Ciba Found Symp 1993; 173: 262-271.
  • 78. Hickie I, Lloyd A, Hadzi-Pavlovic D, et al. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med 1995; 25: 925-935.
  • 79. Gomborone JE, Gorard DA, Dewsnap PA, et al. Prevalence of irritable bowel syndrome in chronic fatigue. J R Coll Physicians Lond 1996; 30: 512-513.
  • 80. Buchwald D. Fibromyalgia and chronic fatigue syndrome: similarities and differences. Rheum Dis Clin North Am 1996; 22: 219-243.
  • 81. Fischler B, Cluydts R, De Gucht V, et al. Generalized anxiety disorder in chronic fatigue syndrome. Acta Psychiatr Scand 1997; 95: 405-413.
  • 82. Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med 2001; 134: 868-881.
  • 83. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M. How many functional somatic syndromes? J Psychosom Res 2001; 51: 549-557.
  • 84. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 1990; 33: 160-172.
  • 85. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: disability and health-care use. Med Care 1996; 34: 924-930.
  • 86. Demitrack M, Crofford L. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998; 840: 684-697.
  • 87. Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med 2000; 62: 655-663.
  • 88. Aaron L, Burke M, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Int Med 2000; 160: 221-227.
  • 89. Buskila D. Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 2001; 13: 117-127.
  • 90. Katon W, Russo J. Chronic fatigue syndrome criteria: a critique of the requirement for multiple physical complaints. Arch Intern Med 1992; 152: 1604-1609.
  • 91. Katon WJ, Walker EA. The relationship of chronic fatigue to psychiatric illness in community, primary care and tertiary care samples. Ciba Found Symp 1993; 173: 193-204.
  • 92. Taerk GS, Toner BB, Salit IE, et al. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis). Int J Psychiatry Med 1987; 17: 49-56.
  • 93. Kruesi MJP, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry 1989; 50: 53-56.
  • 94. Gold D, Bowden R, Sixbey J, et al. Chronic fatigue. A prospective clinical and virologic study. JAMA 1990; 264: 48-53.
  • 95. Hickie I, Lloyd A, Wakefield D, Parker G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry 1990; 156: 534-540.
  • 96. Katon WJ, Buchwald DS, Simon GE, et al. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med 1991; 6: 277-285.
  • 97. Wood GC, Bentall RP, Gopfert M, Edwards RHT. A comparative psychiatric assessment of patients with chronic fatigue syndrome and muscle disease. Psychol Med 1991; 21: 619-628.
  • 98. Buchwald D, Pearlman T, Kith P, et al. Screening for psychiatric disorders in chronic fatigue and chronic fatigue syndrome. J Psychosom Res 1997; 42: 87-94.
  • 99. Hudson JI, Pope HG. The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am 1996; 22: 285-303.
  • 100. Langeluddecke PM. Psychological aspects of irritable bowel syndrome. Aust N Z J Psychiatry 1985; 19: 218-226.
  • 101. Walker EA, Gelfand AN, Gelfand MD, Katon WJ. Psychiatric diagnosis, sexual and physical victimization and disability in patients with irritable bowel syndrome or inflammatory bowel disease. Psychol Med 1995; 25: 1259-1267.
  • 102. Reiger DA, Boyd JH, Burke JD, et al. One-month prevalence of mental disorders in the United States: based on five epidemiologic catchment area sites. Arch Gen Psychiatry 1988; 45: 977-986.
  • 103. Wells JE, Bushnell JA, Hornblow AR, et al. Christchurch psychiatric epidemiology study, part 1: methodology and lifetime prevalence for specific pyschiatric disorders. Aust N Z J Psych 1989; 23: 315-326.
  • 104. Kessler KC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994; 51: 8-19.
  • 105. Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the national comorbidity survey. Am J Psychiatry 1994; 151: 979-986.
  • 106. Mason P, Wilkinson G. The prevalence of psychiatric morbidity: OPCS survey of psychiatric morbidity in Great Britain. Br J Psychiatry 1996; 168: 1-3.
  • 107. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association, 1994.
  • 108. World Health Organization. The tenth revision of the international classification of diseases and related health problems (ICD-10). Geneva: WHO, 1992.
  • 109. Lane TJ, Manu P, Matthews DA. Depression and somatization in the chronic fatigue syndrome. Am J Med 1991; 91: 335-344.
  • 110. Abbey SE. Somatization, illness attribution and the sociocultural psychiatry of chronic fatigue syndrome. Ciba Found Symp 1993; 173: 238-252.
  • 111. Johnson SK, DeLuca J, Natelson BH. Assessing somatization disorder in the chronic fatigue syndrome. Psychosom Med 1996; 58: 50-57.
  • 112. Fischler B, Le Bon O, Hoffman G, et al. Sleep anomalies in the chronic fatigue syndrome: a comorbidity study. Neuropsychobiology 1997; 35: 115-122.
  • 113. Wilson A, Hickie I, Hadzi-Pavlovic D, et al. What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psych 2001; 35: 520-527.
  • 114. Wessely S, Nimnuan C, Sharpe M. Functional somatic syndromes: one or many? Lancet 1999; 354: 936-939.
  • 115. Loblay RH, Swain AR. The role of food intolerance in chronic fatigue syndrome. In: Hyde BM, editor. The clinical and scientific basis of myalgic encephalomyelitis/chronic fatigue syndrome. New York: The Nightingale Research Foundation, 1992.
  • 116. Manu P, Matthews DA, Lane TJ. Food intolerance in patients with chronic fatigue. Int J Eat Disord 1993; 13: 203-209.
  • 117. Kilburn KH. Symptoms, syndrome, and semantics: multiple chemical sensitivity and chronic fatigue syndrome. Arch Environ Health 1993; 48: 368-369.
  • 118. Buchwald D, Garrity D. Comparison of patients with chronic fatigue syndrome, fibromyalgia and multiple chemical sensitivities. Arch Intern Med 1994; 154: 2049-2053.
  • 119. Ziem G, Donnay A. Chronic fatigue, fibromyalgia, and chemical sensitivity: overlapping disorders. Arch Intern Med 1995; 155: 1913.
  • 120. Fiedler N, Kipen HM, DeLuca J, et al. A controlled comparison of multiple chemical sensitivities and chronic fatigue syndrome. Psychosom Med 1996; 58: 38-49.
  • 121. Weiss B. Neurobehavioral properties of chemical sensitivity syndromes. Neurotoxicology 1998; 19: 259-268.
  • 122. Bell IR, Baldwin CM, Schwartz GE. Illness from low levels of environmental chemicals: relevance to chronic fatigue syndrome and fibromyalgia. Am J Med 1998; 105: 74S-82S.
  • 123. Bell IR, Patarca R, Baldwin CM, et al. Serum neopterin and somatization in women with chemical intolerance, depressives, and normals. Neuropsychobiology 1998; 38: 13-18.
  • 124. Kipen HM, Hallman W, Kang H, et al. Prevalence of chronic fatigue and chemical sensitivities in Gulf Registry Veterans. Arch Environ Health 1999; 54: 313-318.
  • 125. Pollet C, Natelson BH, Lange G, et al. Medical evaluation of Persian Gulf veterans with fatigue and/or chemical sensitivity. J Med 1998; 29: 101-113.
  • 126. Lange G, Tiersky L, DeLuca J, et al. Psychiatric diagnoses in Gulf War veterans with fatiguing illness. Psychiatry Res 1999; 89: 39-48.
  • 127. Fiedler N, Lange G, Tiersky L, et al. Stressors, personality traits, and coping of Gulf War veterans with chronic fatigue. J Psychosom Res 2000; 48: 525-535.
  • 128. Reid S, Hotopf M, Hull L, et al. Multiple chemical sensitivity and chronic fatigue syndrome in British Gulf War veterans. Am J Epidemiol 2001; 153: 604-609.
  • 129. Chester AC, Levine PH. The natural history of concurrent sick building syndrome and chronic fatigue syndrome. J Psychiat Res 1997; 31: 51-57.
  • 130. Wessely S. Chronic fatigue syndrome: a 20th century illness? Scand J Work Environ Health 1997; 23: 17-34.
  • 131. Hyams KC. Developing case definitions for symptom-based conditions: the problem of specificity. Epidemiol Rev 1998; 20: 148-156.
  • 132. Barsky AJ, Borus JF. Functional somatic syndromes. Ann Intern Med 1999; 130: 910-921.
  • 133. Meggs WJ. Gulf War syndrome, chronic fatigue syndrome, and the multiple chemical sensitivity syndrome: stirring the cauldron of confusion. Arch Environ Health 1999; 54: 309-311.
  • 134. Neerinckx E, Van Houdenhove B, Lysens R, et al. Attributions in chronic fatigue syndrome and fibromyalgia syndrome in tertiary care. J Rheumatol 2000; 27: 1051-1055.
  • 135. Caccappolo E, Kipen H, Kelly-McNeil K, et al. Odor perception: multiple chemical sensitivities, chronic fatigue, and asthma. J Occup Environ Med 2000; 42: 629-638.
  • 136. Nawab SS, Miller CS, Dale JK, et al. Self-reported sensitivity to chemical exposures in five clinical populations and healthy controls. Psychiatry Res 2000; 95: 67-74.
  • 137. Sparks PJ, editor. Multiple chemical sensitivity/idiopathic environmental intolerance. Occupational Medicine: State of the Art Reviews. Vol. 15. Philadelphia: Hanley & Belfus Medical Publishers, 2000.
  • 138. Petrie KJ, Sivertsen B, Hysing M, et al. Thoroughly modern worries: the relationship of worries about modernity to reported symptoms, health and medical care utlization. J Psychosom Res 2001; 51: 295-401.
  • 139. Joyce J, Hotopf M, Wessely S. The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review. QJM 1997; 90: 223-233.
  • 140. Vercoulen JHMM, Swanink CMA, Fennis JFM, et al. Prognosis in chronic fatigue syndrome: a prospective study on the natural course. J Neurol Neurosurg Psychiatry 1996; 60: 489-494.
  • 141. Bombardier CH, Buchwald D. Outcome and prognosis of patients with chronic fatigue vs chronic fatigue syndrome. Arch Intern Med 1995; 155: 2105-2110.
  • 142. Tirelli V, Pinto A, Marotta G, et al. Clinical and immunologic study of 205 patients with chronic fatigue syndrome: a case series from Italy. Arch Intern Med 1993; 153: 116-117,120.
  • 143. Ray C, Jefferies S, Weir WRC. Coping and other predictors of outcome in chronic fatigue syndrome: a 1-year follow-up. J Psychosom Res 1997; 43: 405-415.
  • 144. Reyes M, Dobbins JG, Nisenbaum R, et al. Chronic fatigue syndrome progression and self-defined recovery: evidence from the CDC surveillance system. J Chronic Fatigue Syndr 1999; 5: 7-17.
  • 145. Peterson PK, Schenk CH, Sherman R. Chronic fatigue in Minnesota. Minnesota Med 1991; 74: 21-26.
  • 146. Sharpe M, Hawton K, Seagroatt V, Pasvol G. Follow up of patients presenting with fatigue to an infectious diseases clinic. BMJ 1992; 305: 147-152.
  • 147. Hinds GME, McCluskey DR. A retrospective study of the chronic fatigue syndrome. Proc R Coll Physicians Edin 1993; 23: 10-14.
  • 148. Bonner D, Butler S, Chalder T, et al. A follow up study of chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1994; 57: 617-621.
  • 149. Tirelli U, Marotta G, Improta S, Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scand J Immunol 1994; 40: 601-608.
  • 150. Wilson A, Hickie I, Lloyd A, et al. Longitudinal study of outcome of chronic fatigue syndrome. BMJ 1994; 308: 756-759.
  • 151. Ray C, Jefferies S, Weir WRC. Life-events and the course of chronic fatigue syndrome. Br J Med Psychol 1995; 68: 323-331.
  • 152. Bruce-Jones WDA, White PD, Thomas JM, Clare AW. The effect of social adversity on the fatigue syndrome, psychiatric disorders and physical recovery, following glandular fever. Psychol Med 1994; 24: 651-659.
  • 153. Wilson A, Hickie I, Lloyd A, Wakefield D. The treatment of chronic fatigue syndrome: science and speculation. Am J Med 1994; 96: 544-550.
  • 154. Hill NF, Tiersky LA, Scavalla VR, et al. Natural history of severe chronic fatigue syndrome. Arch Phys Med Rehabil 1999; 80: 1090-1094.
  • 155. Tiersky LA, DeLuca J, Hill N, et al. Longitudinal assessment of neuropsychological functioning, psychiatric status, functional disability and employment status in chronic fatigue syndrome. Appl Neuropsych 2001; 8: 41-50.
  • 156. Friedberg F, Dechene L, McKenzie MJI, Fontanetta R. Symptom patterns in long-duration chronic fatigue syndrome. J Psychosom Res 2000; 48: 59-68.
  • 157. Feder HM, Dworkin PH, Orkin C. Outcome of 48 pediatric patients with chronic fatigue. Arch Fam Med 1994; 3: 1049-1055.
  • 158. Carter BD, Edwards JF, Kronenberger WG, et al. Case control study of chronic fatigue in pediatric patients. Pediatrics 1995; 95: 179-186.
  • 159. Krilov LR, Fisher M, Friedman SB, et al. Course and outcomes of chronic fatigue in children and adolescents. Pediatrics 1998: 102; 360-366.
  • 160. Marshall GS. Report of a workshop on the epidemiology, natural history, and pathogenesis of chronic fatigue syndrome in adolescents. J Pediatr 1999; 134: 395-405.
  • 161. Rowe KS. Five-year follow-up of young people with chronic fatigue syndrome following the double blind randomised controlled intravenous gammaglobulin trial. J Chronic Fatigue Syndr 1999; 5: 97-107.
  • 162. Rowe KS, Rowe KJ. Follow up of 200 young people with CFS -- relationship of functional outcomes to symptom patterns and psychological features. Proceedings of the 5th International Conference of the American Association of Chronic Fatigue Syndrome, Seattle Washington Jan 24-26, 2001: A92.
  • 163. Bell DS, Jordan K, Robinson M. Thirteen-year follow up of children and adolescents with chronic fatigue syndrome. Pediatrics 2001; 107: 994-998.
  • 164. Straus SE. Studies of herpesvirus infection in chronic fatigue syndrome. Ciba Found Symp 1993; 173: 132-139.
  • 165. Lloyd AR, Wakefield D, Hickie I. Immunity and the pathophysiology of chronic fatigue syndrome. Ciba Found Symp 1993; 173: 176-187.
  • 166. Komaroff AL. The biology of chronic fatigue syndrome. Am J Med 2000; 108: 169-171.
  • 167. Demitrack MA. Neuroendocrine aspects of chronic fatigue syndrome: implications for diagnosis and research? In: Straus SE, editor. Chronic fatigue syndrome. New York: Marcel Dekker, 1994: 285-308.
  • 168. Demitrack MA. Neuroedocrine aspects of chronic fatigue syndrome: a commentary. Am J Med 1998; 105: 11S-14S.
  • 169. Wessely S. The neuropsychiatry of chronic fatigue syndrome. Ciba Found Symp 1993; 173: 212-229.
  • 170. Imboden JB, Canter A, Cluff LE. Convalescence from influenza: a study of the psychological and clinical determinants. Arch Intern Med 1961; 108: 393-399.
  • 171. White PD. The relationship between infection and fatigue. J Psychosom Res 1997; 43: 345-350.
  • 172. Manu P. Chronic fatigue syndrome: the fundamentals still apply. Am J Med 2000; 108: 172-173.
  • 173. Jones JF, Ray CG, Minnich LL, et al. Evidence of active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 1985; 102: 1-7.
  • 174. Straus SE, Tosato G, Armstrong G, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 1985; 102: 7-16.
  • 175. Buchwald D, Goldenberg DL, Sullivan JL, Komaroff AL. The "chronic active Epstein-Barr virus infection" syndrome and fibromyalgia. Arthritis Rheum 1987; 30: 1132-1136.
  • 176. Buchwald D, Cheney PR, Peterson DL, et al. A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpes type 6 infection. Ann Intern Med 1992; 116: 103-113.
  • 177. Buchwald D, Ashley RL, Pearlman T, et al. Viral serologies in patients with chronic fatigue syndrome. J Med Virol 1996; 50: 25-30.
  • 178. Calder B, Warnock P, McCartney R, Bell E. Coxsackie B viruses and the post-viral syndrome: a prospective study in general practice. J R Coll Gen Pract 1987; 37: 11-14.
  • 179. Holmes GP, Kaplan JE, Stewart JA, et al. A cluster of patients with a chronic mononucleosis-like syndrome: is Epstein-Barr virus the cause? JAMA 1987; 257: 2297-2302.
  • 180. Bell EJ, Riding MH, McCartney RA. Coxsackie B viruses and myalgic encephalomyelitis. J R Soc Med 1988; 81: 329-331.
  • 181. Hellinger WC, Smith TF, Van Scoy RE, et al. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. JAMA 1988; 260: 971-973.
  • 182. Miller NA, Carmichael HA, Calder BD, et al. Antibody to coxsackie B virus in diagnosing postviral fatigue syndrome. BMJ 1991; 302: 140-143.
  • 183. Mawle AC, Nisenbaum R, Dobbins JG, et al. Seroepidemiology of chronic fatigue syndrome: a case-control study. Clin Infect Dis 1995; 21: 1386-1389.
  • 184. Kitani T, Kuratsune H, Fuke I, et al. Possible correlation between Borna disease virus infection and Japanese patients with chronic fatigue syndrome. Microbiol Immunol 1996; 40: 459-462.
  • 185. White PD, Grover SA, Kangro HO, et al. The validity and reliability of the fatigue syndrome that follows glandular fever. Psychol Med 1995; 25: 917-924.
  • 186. White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry 1998; 173: 475-481.
  • 187. Buchwald DS, Rea TD, Katon WJ, et al. Acute infectious mononucleosis: characteristics of patients who report failure to recover. Am J Med 2000; 109: 531-537.
  • 188. White PD, Thomas JM, Kangro HO, et al. Predictions and associations of fatigue syndromes and mood disorders that occur after infectious mononucleosis. Lancet 2001; 358: 1946-1954.
  • 189. Sumaya C. Serologic and virologic epidemiology of Epstein-Barr virus: relevance to chronic fatigue syndrome. Rev Infect Dis 1990; 13 Suppl 1: S19-S25.
  • 190. Jones JF. Viral etiology of chronic fatigue syndrome. In: Goodnick PJ, Klimas NG, editors. Chronic fatigue and related immune deficiency syndromes. Washington: American Psychiatric Press; 1993; 23-43.
  • 191. Wallace HL 2nd, Natelson B, Gause W, et al. Human herpesviruses in chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6: 216-223.
  • 192. Archard LC, Bowles NE, Behan PO, et al. Post-viral fatigue syndrome: persistence of enteroviral RNA in muscle biopsy samples. J R Soc Med 1988; 81: 326-329.
  • 193. Gow JW, Behan WMH, Clements GB, et al. Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ 1991; 302: 692-696.
  • 194. Gow JW, Behan WMH, Simpson K, et al. Studies on enteroviruses in patients with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl 1: S126-S129.
  • 195. Bowles NE, Bayson TA, Zhang HY, et al. Persistence of enterovirus RNA in muscle biopsy samples. J Med 1993; 24: 145-160.
  • 196. Clements GB, McGarry F, Nairn C, Galbraith DN. Detection of enterovirus-specific RNA in serum: the relationship to chronic fatigue. J Med Virol 1995; 45: 156-161.
  • 197. Galbraith DN, Nairn C, Clements GB. Phylogenic analysis of short enteroviral sequences from patients with chronic fatigue syndrome. J Gen Virol 1995; 76: 1701-1707.
  • 198. Mawle AC, Nisenbaum R, Dobbins JG, et al. Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis 1997; 175: 136-141.
  • 199. McArdle A, McArdle M, Jackson MJ, et al. Investigation by polymerase chain reaction of enteroviral infection in patients with chronic fatigue syndrome. Clin Sci 1996; 90: 295-300.
  • 200. Lindh G, Samuelson A, Hedlund K, et al. No findings of enteroviruses in Swedish patients with chronic fatigue syndrome. Scan J infect Dis 1996; 28: 305-307.
  • 201. Defreitas E, Hilliard B, Cheney PR, et al. Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome. Proc Natl Acad Sci USA 1991; 88: 2922-2926.
  • 202. Flugel RM, Mahnke C, Geiger A, Komaroff AL. Absence of antibody to human spumaretrovirus in patients with chronic fatigue syndrome [letter]. Clin Infect Dis 1992; 14: 623-624.
  • 203. Gow JW, Simpson K, Schliephake A, et al. Search for a retrovirus in the chronic fatigue syndrome. J Clin Pathol 1992; 145: 1058-1061.
  • 204. Folks TM, Heneine W, Khan A, et al. Investigation of retroviral involvement in chronic fatigue syndrome. Ciba Found Symp 1993; 173: 160-166.
  • 205. Khan AS, Heneine WM, Chapman LE, et al. Assessment of a retrovirus sequence and other possible risk factors for the chronic fatigue syndrome in adults. Ann Intern Med 1993; 118: 241-245.
  • 206. Honda M, Kitamura K, Nakasone T, et al. Japanese patients with chronic fatigue syndrome are negative for known retrovirus infections. Microbiol Immunol 1993; 37: 779-784.
  • 207. Heneine W, Woods TC, Sinha SD, et al. Lack of evidence for infection with known human and animal retroviruses in patients with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl 1: S121-S125.
  • 208. Gelman IH, Unger ER, Mawle AC, et al. Chronic fatigue syndrome is not associated with expression of endogenous retroviral p15E. Mol Diagn 2000; 5: 155-1556.
  • 209. Hay J, Jenkins FJ. Human herpesviruses and chronic fatigue syndrome. In: Straus SE, editor. Chronic fatigue syndrome. New York: Marcel Dekker, 1994: 181-197.
  • 210. Yalcin S, Kuratsune H, Yamaguchi K, et al. Prevalence of human herpesvirus 6 variants A and B in patients with chronic fatigue syndrome. Microbiol Immunol 1994; 38: 587-590.
  • 211. DiLuca D, Zorzenon M, Mirandola P, et al. Human herpesvirus 6 and human herpesvirus 7 in chronic fatigue syndrome. J Clin Microbiol 1995; 33: 1660-1661.
  • 212. Patnaik M, Komaroff AL, Conley E, et al. Prevalence of IgM antibodies to human herpesvirus 6 (HHV-6) early antigen (P41/38) in patients with chronic fatigue syndrome. J Infect Dis 1995; 172: 1364-1367. [Published erratum appears in J Infect Dis 1995; 172: 1643].
  • 213. Vojdani A, Lapp CW. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacol Immunotoxicol 1999; 21: 175-202.
  • 214. Ablashi DV, Eastman HB, Owen CB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol 2000; 16: 179-191.
  • 215. Reeves WC, Stamey FR, Black JB, et al. Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study. Clin Infect Dis 2000; 31: 48-52.
  • 216. Enbom M, Linde A, Evengard B. No evidence of active infection with human herpesvirus 6 (HHV-6) or HHV-8 in chronic fatigue syndrome. J Clin Microbiol 2000; 38: 2457.
  • 217. Westley-Wise VJ, Beard JR, et al. Ross River virus infection on the North Coast of New South Wales. Aust N Z J Public Health 1996; 20: 87-92.
  • 218. Bode L, Komaroff AL, Ludwig H. No serologic evidence of borna disease virus in patients with chronic fatigue syndrome. Clin Infect Dis 1992; 15: 1049.
  • 219. Nakaya T, Takahashi H, Nakamura Y, et al. Demonstration of borna disease virus RNA in peripheral blood mononuclear cells derived from Japanese patients with chronic fatigue syndrome. FEBS Lett 1996; 378: 145-149.
  • 220. Evengard B, Briese T, Lindh G, et al. Absence of evidence of borna disease virus infection in Swedish patients with chronic fatigue syndrome. J Neurovirol 1999; 5: 495-499.
  • 221. Nakaya T, Takahashi H, Nakamura Y, et al. Borna disease virus infection in two family clusters of patients with chronic fatigue syndrome. Microbiol Immunol 1999; 43: 679-689.
  • 222. Yamaguchi K, Sawada T, Naraki T, et al. Detection of borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay. Clin Diagn Lab Immunol 1999; 6: 696-700.
  • 223. Bujak DI, Rich T, Dornbush RL, Weinstein A. Fibromyalgia and chronic fatigue syndrome induced by Lyme disease. Ann Rheum Dis 1993; 52: 404.
  • 224. Bujak DI, Weinstein A, Dornbush RL. Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 1996; 23: 1392-1397.
  • 225. Shaddick NA, Phillips CB, Logigian EL, et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994; 121: 560-567.
  • 226. Sigal LH. Persistent complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. Am J Med 1994; 96: 365-374.
  • 227. Ayres JG, Smith EG, Flint N. Protracted fatigue and debility after acute Q fever. Lancet 1996; 347: 978-979.
  • 228. Ayres JG, Flint N, Smith EG, et al. Post-infection fatigue syndrome following Q fever. QJM 1998; 91: 105-123.
  • 229. Hudson BJ, Barry RD, Shafren DR, et al. Does Lyme borreliosis exist in Australia? J Spirochetal Tick Borne Dis 1994; 1: 46-52.
  • 230. Choppa PC, Vojdani A, Tagle C, et al. Multiplex PCR for the detection of Mycoplasma fermentans, M. hominis and M. penetrans in cell cultures and blood samples of patients with chronic fatigue syndrome. Mol Cell Probes 1998; 12: 301-308.
  • 231. Vojdani A, Choppa PC, Tagle C, et al. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol 1998; 22: 355-365.
  • 232. Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and/or fibromyalgia syndrome. Eur J Clin Microbiol Infect Dis 1999; 18: 859-865.
  • 233. Strober W. Immunological function in chronic fatigue syndrome. In: Straus SE, editor. Chronic fatigue syndrome. New York: Marcel Dekker, 1994: 207-237.
  • 234. Keller RH, Lane JL, Klimas N, et al. Association between HLA Class II antigens and chronic fatigue immune dysfunction syndrome. Clin Infect Dis 1994; 18 (Suppl 1): S154-S156.
  • 235. Underhill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogen 2001; 28: 425-428.
  • 236. Behan P, Behan W, Bell E. The postviral fatigue syndrome - an analysis of the findings in 50 cases. J Infect 1985; 10: 211-222.
  • 237. Kibler R, Lucas D, Hicks M, et al. Immune function in chronic active Epstein-Barr virus infection. J Clin Immunol 1985; 5: 46-54.
  • 238. Caliguri M, Murray C, Buchwald D, et al. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139: 3306-3313.
  • 239. Lloyd AR, Wakefield D, Dwyer J, Boughton C. Immunologic abnormalities in the chronic fatigue syndrome. Med J Aust 1989; 151: 122-124.
  • 240. Klimas N, Salvato F, Morgan R, Fletcher M. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403-1410.
  • 241. Gupta S, Vayuvegula B. A comprehensive immunological analysis in chronic fatigue syndrome. Scand J Immunol 1991; 33: 319-327.
  • 242. Landay A, Jessop C, Lennette E, Levy J. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991; 338: 707-712.
  • 243. Ho-Yen D, Billington R, Urquhart J. Natural killer cells and the post-viral fatigue syndrome. Scand J Infect Dis 1991; 23: 711-716.
  • 244. Morrison L, Behan W, Behan P. Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol 1991; 83: 441-446.
  • 245. Lloyd A, Hickie I, Hickie C, Wakefield D. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol 1992; 87: 76-79.
  • 246. Straus S, Fritz S, Dale J, et al. Lymphocyte phenotype and function in the chronic fatigue syndrome. J Clin Immunol 1993; 13: 30-40.
  • 247. Barker A, Fujimura S, Fadem M, et al. Immunologic abnormalities in association with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl 1: S136-S141.
  • 248. Ojo-Amaize E, Conley E, Peter J. Decreased natural killer cell activity is associated with severity of chronic fatigue syndrome immune dysfunction syndrome. Clin Infect Dis 1994; 18 Suppl 1: S157-S159.
  • 249. Peakman M, Deale A, Field R, et al. Clinical improvement in chronic fatigue syndrome is not associated with lymphocyte subsets of function or activation. Clin Immunol Immunopathol 1997; 82: 83-91.
  • 250. Ogawa M, Nishiura T, Yoshimura M, et al. Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome. Eur J Clin Invest 1998; 28: 937-943.
  • 251. Whiteside TL, Friberg D. Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 1998; 105: 27S-34S.
  • 252. Levine PH, Whiteside TL, Friberg D, et al. Dysfunction of natural killer activity in a family with chronic fatigue syndrome. Clin Immunol Immunopathol 1998; 88: 96-104.
  • 253. Abbot NC, Spence VA, Lowe JG, et al. Immunological findings may vary between populations [letter]. BMJ 1994; 308: 1299.
  • 254. Swanink CMA, Vercoulen JHMM, Galama JMD, et al. Lymphocyte subsets, apoptosis, and cytokines in patients with chronic fatigue syndrome. J Infect Dis 1996; 173: 460-463.
  • 255. Vojdani M, Ghoneum M, Choppa PC, et al. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Intern Med 1997; 242: 465-478.
  • 256. Natelson BH, LaManca JJ, Denny TN, et al. Immunologic parameters in chronic fatigue syndrome, major depression, and multiple sclerosis. Am J Med 1998; 105: 43S-49S.
  • 257. Hassan IS, Bannister BA, Akbar A, et al. A study of the immunology of the chronic fatigue syndrome: correlation of immunologic parameters to health dysfunction. Clin Immunol Immunopathol 1998; 87: 60-67.
  • 258. LaManca JJ, Sisto SA, Zhou XD, et al. Immunological response in chronic fatigue syndrome following a graded exercise test to exhaustion. J Clin Immunol 1999; 19: 135-142.
  • 259. Hanson SJ, Gause W, Natelson B. Detection of immunologically significant factors for chronic fatigue syndrome using neural-network classifiers. Clin Diag Lab Immunol 2001; 8: 658-662.
  • 260. Bennett AL, Fagioli LR, Schur PH, et al. Immunoglobulin subclass levels in chronic fatigue syndrome. J Clin Immunol 1996; 16: 315-320.
  • 261. Read R, Spickett G, Harvey J, et al. IgG1 subclass deficiency in patients with chronic fatigue syndrome [letter]. Lancet 1988; 1: 241-242.
  • 262. Linde A, Hammarstrom L, Smith CI. IgG subclass deficiency and chronic fatigue syndrome [letter]. Lancet 1988; 1: 885-886.
  • 263. Wakefield D, Lloyd A, Brockman A. Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome. Pediatr Infect Dis J 1990; 9 Suppl 8: S50-S53.
  • 264. Peterson PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89: 554-560.
  • 265. Tobi M, Morang A, Ravid Z. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982; 1: 61.
  • 266. Tobi M, Straus SE. Chronic Epstein-Barr virus disease. Ann Intern Med 1985; 103: 951-953.
  • 267. Olson GB, Kanaan MN, Gersuk GM, et al. Correlation between allergy and persistent Epstein-Barr virus infections in chronic active Epstein-Barr virus-infected patients. J Allergy Clin Immunol 1986; 78: 308-314.
  • 268. Olson GB, Kanaan MN, Kelley LM, Jones JF. Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic active Epstein-Barr virus infections. J Allergy Clin Immunol 1986; 78: 315-320.
  • 269. Straus SE, Dale JK, Wright R, et al. Allergy and the chronic fatigue syndrome. J Allergy Clin Immunol 1988; 81: 791-795.
  • 270. MacDonald KL, Osterholm MT, LeDell KH, et al. A case-control study to assess possible triggers and cofactors in chronic fatigue syndrome. Am J Med 1996; 100: 548-554.
  • 271. Borish L, Schmaling K, DiClementi JD, et al. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allergy Clin Immunol 1998; 102: 222-230.
  • 272. Repka-Ramirez MS, Naranch K, Park YJ, et al. IgE levels are the same in chronic fatigue syndrome (CFS) and control subjects when stratified by allergy skin test results and rhinitis types. Ann Allergy Asthma Immunol 2001; 87: 218-221.
  • 273. Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with chronic fatigue syndrome. Am J Med 1990; 89: 561-568.
  • 274. Bennett BK, Hickie IB, Vollmer-Conna US, et al. The relationship between fatigue, psychological and immunological variables in acute infectious illness. Aust N Z J Psychiatry 1998; 32: 180-186.
  • 275. Hickie I, Koschera A, Hadzi-Pavlovic D, et al. The temporal stability and co-morbidity of prolonged fatigue: a longitudinal study in primary care. Psychol Med 1999; 29: 855-861.
  • 276. Lever AML, Lewis DM, Bannistr BA, et al. Interferon production in postviral fatigue syndrome [letter]. Lancet 1988; 2: 101.
  • 277. Lloyd A, Hickie I, Brockman A, et al. Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis 1991; 164: 1023-1024.
  • 278. Morte S, Castilla A, Civiera M-P, et al. Gamma interferon and chronic fatigue syndrome. Lancet 1988; 2: 623-624.
  • 279. Morte S, Castilla A, Civiera M-P, et al. Production of interleukin-1 by peripheral blood mononuclear cells in patients with chronic fatigue syndrome. J Infect Dis 1989; 159: 362.
  • 280. Cheney PR, Dorman SE, Bell DS. Interleukin-2 and the chronic fatigue syndrome. Ann Intern Med 1989; 110: 321.
  • 281. Straus S, Dale JK, Peter JB, Dinarello CA. Circulating lymphokine levels in the chronic fatigue syndrome. J Infect Dis 1989; 160: 1085-1086.
  • 282. Chao CC, Gallagher M, Phair J, Peterson PK. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis 1990; 162: 1412-1413.
  • 283. Chao CC, Janoff EN, Hu S, et al. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine 1991; 3: 292-298.
  • 284. Linde A, Andersson B, Svenson SB, et al. Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992; 165: 994-1000.
  • 285. Lloyd A, Gandevia S, Brockman A, et al. Cytokine production and fatigue in patients with chronic fatigue syndrome and healthy control subjects in response to exercise. Clin Infect Dis 1994; 18 Suppl 1: S142-S146.
  • 286. Swanink CM, Vercoulen JH, Bleijenberg G, et al. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J Intern Med 1995; 237: 499-506.
  • 287. Buchwald D, Wener MH, Pearlman T, Kith P. Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J Rheumatol 1997; 24: 372-376.
  • 288. Cannon JG, Angel JB, Abad LW, et al. Interleukin-1 beta, Interleukin-1 receptor antagonist, and soluble Interleukin-1 receptor type II secretion in chronic fatigue syndrome. J Clin Immunol 1997; 17: 253-261.
  • 289. Vollmer-Conna U, Lloyd A, Hickie I, et al. Chronic fatigue syndrome: an immunological perspective. Aust N Z J Psychiatry 1998; 32: 523-527.
  • 290. Visser J, Blauw B, Hinloopen B, et al. CD4 T lymphocytes from patients with chronic fatigue syndrome have decreased interferon-gamma production and increased sensitivity to dexamethasone. J Infect Dis 1998; 177: 451-454.
  • 291. Zhang Q, Zhou XD, Denny T, et al. Changes in immune parameters seen in Gulf War veterans but not in civilians with chronic fatigue syndrome. Clin Diagn Lab Immunol 1999; 6: 6-13.
  • 292. Patarca-Montero R, Antoni M, Fletcher MA, et al. Cytokine and other immunologic markers in chronic fatigue syndrome and their relation to neuropsychological factors. Appl Neuropsychol 2001; 8: 51-64.
  • 293. Suhadolnik RJ, Reichenback NL, Hitzges P, et al. Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl 1: S96-S104.
  • 294. Suhadolnik RJ, Peterson DL, O'Brien K, et al. Biochemical evidence for a novel low molecular weight 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 1997; 17: 377-385.
  • 295. DeMeirleir K, Bisbal C, Campine I, et al. A 37 kDa 2-5A binding protein as a potential biochemical marker for chronic fatigue syndrome. Am J Med 2000; 108: 99-105.
  • 296. Konstantinov K, von Mikecz A, Buchwald D, et al. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest 1996; 98: 1888-1896.
  • 297. von Mikecz A, Konstantinov K, Buchwald DS, et al. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheum 1997; 40: 295-305.
  • 298. Plioplys AV. Antimuscle and anti-CNS circulating antibodies in chronic fatigue syndrome. Neurology 1997; 48: 1717-1719.
  • 299. Nishikai M, Tomomatsu S, Hankins RW, et al. Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology (Oxford) 2001; 40: 806-810.
  • 300. Kuratsune H, Yamaguti K, Hattori H, et al. Symptoms, signs and laboratory findings in patients with chronic fatigue syndrome. Nippon Rinsho 1992; 50: 2665-2672.
  • 301. Calabrese LH, Davis ME, Wilke WS. Chronic fatigue syndrome and a disorder resembling Sjogren's syndrome: preliminary report. Clin Infect Dis 1994; 18 Suppl 1: S28-S31.
  • 302. Nishikai M, Akiya K, Tojo T, et al. 'Seronegative' Sjogren's syndrome manifested as a subset of chronic fatigue syndrome. Br J Rheumatol 1996; 35: 471-474.
  • 303. Lieberman J, Bell DS. Serum angiotensin-converting enzyme as a marker for the chronic fatigue-immune dysfunction syndrome: a comparison to serum angiotensin-converting enzyme in sarcoidosis. Am J Med 1993; 95: 407-412.
  • 304. Demitrack MA, Dale JK, Straus SE, et al. Impaired activation of the hypothalamic-pituitary-adrenal axis in a patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-1234.
  • 305. Bakheit AMO, Behan PO, Watson WA, et al. Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. BMJ 1992; 304: 1010-1012.
  • 306. Bearn J, Allain T, Coskeran P, et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995; 37: 245-252.
  • 307. Cleare AJ, Bearn J, McGregor A, et al. Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord 1995; 35: 283-289.
  • 308. Sharpe M, Hawton K, Clements A, et al. Increased brain serotonin function in men with chronic fatigue syndrome. BMJ 1997; 315: 164-165.
  • 309. Dinan TG, Majeed T, Lavelle E, et al. Blunted serotonin-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychoneuroendocrinology 1997; 22: 261-267.
  • 310. Chaudhuri A, Majeed T, Dinan T, Behan PO. Chronic fatigue syndrome: a disorder of central cholinergic transmission. J Chronic Fatigue Syndr 1997; 3: 3-16.
  • 311. Cannon JG, Angel JB, Abad LW, et al. Hormonal influences on stress-induced neutrophil mobilization in health and chronic fatigue syndrome. J Clin Immunol 1998; 18: 291-298.
  • 312. Young AH, Sharpe M, Clements A, et al. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with the chronic fatigue syndrome (neurasthenia). Biol Psychiatry 1998; 43: 236-237.
  • 313. MacHale SM, Cavanagh JTO, Bennie J, et al. Diurnal variation of adrenocortical activity in chronic fatigue syndrome. Neuropsychobiology 1998; 38: 213-217.
  • 314. Scott LV, Burnett F, Medbak S, et al. Naloxone-mediated activation of the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome. Psychol Med 1998; 28: 285-292.
  • 315. Scott LV, Dinan TG. Urinary free cortisol excretion in chronic fatigue syndrome, major depression and in healthy volunteers. J Affect Disord 1998; 47: 49-54.
  • 316. Scott LV, Medbak S, Dinan TG. Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome. Acta Psychiatr Scand 1998; 97: 450-457.
  • 317. Scott LV, Medbak S, Dinan TG. The low dose ACTH test in chronic fatigue syndrome and in health. Clin Endocrinol 1998; 48: 733-737.
  • 318. Scott LV, Teh J, Reznek R, et al. Small adrenal glands in chronic fatigue syndrome: a preliminary computed tomography study. Psychoneuroendocrinology 1999; 24: 759-768.
  • 319. Kavelaars A, Kuis W, Knook L, et al. Disturbed neuroendocrine-immune interactions in chronic fatigue syndrome. J Clin Endocrinol Metab 2000; 85: 692-696.
  • 320. Korszun A, Young EA, Engleberg NC, et al. Follicular phase hypothalamic-pituitary-gonadal axis function in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 2000; 27: 1526-1530.
  • 321. Altemus M, Dale JK, Michelson D, et al. Abnormalities in response to vasopressin infusion in chronic fatigue syndrome. Psychoneuroendocrinol 2001; 26: 175-188.
  • 322. Cleare AJ, Miell J, Heap E, et al. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. J Clin Endocrinol Metab 2001; 86: 3545-3554.
  • 323. Ottenweller JE, Sisto SA, McCarty RC et al. Hormonal responses to exercise in chronic fatigue syndrome. Neuropsychobiology 2001; 43: 34-41.
  • 324. Buchwald D, Umali J, Stene M. Insulin-like growth factor-I (somatomedin C) levels in chronic fatigue syndrome and fibromyalgia. J Rheumatol 1996; 23: 739-742.
  • 325. Bennett AL, Chao CC, Hu S, et al. Elevation of bioactive transforming growth factor-B in serum from patients with chronic fatigue syndrome. J Clin Immunol 1997; 17: 160-166.
  • 326. Bennett AL, Mayes DM, Fagioli LR, et al. Somatomedin C (insulin-like growth factor 1) levels in patients with chronic fatigue syndrome. J Psychiat Res 1997; 31: 91-96.
  • 327. Allain TJ, Bearn JA, Coskeran P, et al. Changes in growth hormone, insulin, insulinlike growth factors (IGFs), and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 1997; 41: 567-573.
  • 328. Whelton CL, Salit I, Moldofsky H. Sleep, Epstein-Barr virus infection, musculoskeletal pain, and depressive symptoms in chronic fatigue syndrome. J Rheumatol 1992; 19: 939-943.
  • 329. Morriss R, Sharpe M, Sharpley AL, et al. Abnormalities of sleep in patients with the chronic fatigue syndrome. BMJ 1993; 306: 1161-1164.
  • 330. Krupp LB, Jandorf JL, Coyle PK, Mendelson WB. Sleep disturbances in chronic fatigue syndrome. J Psychosom Res 1993; 37: 325-331.
  • 331. Buchwald D, Pascualy R, Bombardier C, Kith P. Sleep disorders in patients with chronic fatigue. Clin Infect Dis 1994; 18 Suppl 1: S68-S72.
  • 332. Williams G, Pirmohamed J, Minors D, et al. Dissociation of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome. Clin Physiol 1996; 16: 327-337.
  • 333. Korszun A, Sackett-Lundeen L, Papadopoulos E, et al. Melatonin levels in women with fibromyalgia and chronic fatigue syndrome. J Rheumatol 1999; 26: 2675-2680.
  • 334. Moldofsky H, Scarisbrick P. Introduction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976; 38: 35-44.
  • 335. Leese G, Chattington P, Fraser W, et al. Short-term night shift working mimics the pituitary-adrenocortical dysfunction in chronic fatigue syndrome. J Clin Endocrinol Metab 1996; 81: 1867-1870.
  • 336. Bou-Holaigah I, Rowe PC, Kan J, Calkins H. The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274: 961-967.
  • 337. De Lorenzo F, Hargreaves J, Kakkar VV. Possible relationship between chronic fatigue and postural tachycardia syndromes. Clin Autonom Res 1996; 6: 263-264.
  • 338. Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102: 357-364.
  • 339. Yataco A, Talo H, Rowe P, et al. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clin Autonom Res 1997; 7: 293-297.
  • 340. De Becker P, Dendale P, De Meirleir K, et al. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998; 105: 22S-26S.
  • 341. Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105: 15S-21S.
  • 342. Duprez DA, De Buyzere ML, Drieghe B, et al. Long- and short-term blood pressure and RR-interval variability and psychosomatic distress in chronic fatigue syndrome. Clin Sci 1998; 94: 57-63.
  • 343. Stewart JM, Gewitz MH, Weldon A, et al. Orthostatic intolerance in adolescent chronic fatigue syndrome. Pediatrics 1999; 103: 116-121.
  • 344. Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000; 48: 218-226.
  • 345. LaManca JJ, Peckerman A, Sisto SA, et al. Cardiovascular responses of women with chronic fatigue syndrome to stressful cognitive testing before and after strenuous exercise. Psychosom Med 2001; 63: 756-764.
  • 346. Demitrack MA, Gold PW, Dale JK, et al. Plasma and cerebrospinal fluid monoamine metabolism in patients with chronic fatigue syndrome: preliminary findings. Biol Psychiatry 1992; 32: 1065-1077.
  • 347. Clauw DJ, Sabol M, Radulovic D, et al. Serum neuropeptides in patients with both fibromyalgia (FM) and chronic fatigue syndrome (CFS). J Musculoskel Pain 1995; 3 Suppl 1: S79.
  • 348. Sendrowski DP, Buker EA, Gee SS. An investigation of sympathetic hypersensitivity in chronic fatigue syndrome. Optom Vis Sci 1997; 74: 660-663.
  • 349. Sharpe M, Clements A, Hawton K, et al. Increased prolactin response to buspirone in chronic fatigue syndrome. J Affect Disord 1996; 41: 71-76.
  • 350. Simon TR, Dallas TX, Cowden E, et al. Chronic fatigue syndrome: flow and functional abnormalities seen with SPECT. Radiology 1991; 181 Suppl: 173.
  • 351. Costa DC, Brostoff J, Douli V, Ell PJ. Brain stem hypoperfusion in patients with myalgic encephalomyelitis-chronic fatigue syndrome [abstract]. Eur J Nucl Med 1992; 19: 733.
  • 352. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 1995; 88: 767-773.
  • 353. Ichise M, Salit IE, Abbey SE, et al. Assessment of regional cerebral perfusion by 99m Tc HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun 1992; 13: 767-772.
  • 354. Natelson BH, Cohen JM, Brassloff I, Lee H-J. A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome. J Neurol Sci 1993; 120: 213-217.
  • 355. Schwartz RB, Garada BM, Komaroff AL, et al. Detection of intracranial abnormalities in patients with chronic fatigue: comparison of MR imaging and SPECT. Am J Radiol 1994; 162: 935-941.
  • 356. Schwartz RB, Komaroff AL, Garada BM, et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex and major unipolar depression. Am J Radiol 1994; 162: 943-951.
  • 357. Cope H, Pernet A, Kendall B, David A. Cognitive functioning and magnetic resonance imaging in chronic fatigue. Br J Psychiatry 1995; 167: 86-94.
  • 358. Goldstein JA, Mena I, Jouanne E, Lesser I. The assessment of vascular abnormalities in late life chronic fatigue syndrome by brain SPECT: comparison with late life major depressive disorder. J Chronic Fatigue Syndr 1995; 1: 55-79.
  • 359. Osmanagaoglu K, Lambrecht L, Van de Wiele C, et al. Tc99-HMPAO SPECT and magnetic resonance imaging in 30 patients suffering from chronic fatigue syndrome [abstract]. Neurospect. SPECT in Clinical Neurology and Psychiatry. Acta Neurol Belg 1995; Suppl: 87-88.
  • 360. Patterson J, Aitchison F, Wyper DJ, et al. SPECT brain imaging in chronic fatigue syndrome. J Immunol Immunopharmacol 1995; XV, 1-2: 53-58.
  • 361. Fischler B, D'Haenen H, Cluydts R, et al. Comparison of 99mTc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology 1996; 34: 175-183.
  • 362. Lange G, DeLuca J, Maldjian JA, et al. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci 1999; 171: 1-2.
  • 363. Lewis DH, Mayberg HS, Fischer ME, et al. Monozygotic twins discordant for chronic fatigue syndrome: regional cerebral blood flow spect. Radiology 2001; 219: 766-773.
  • 364. Tirelli U, Chierichetti F, Tavio M, et al. Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med 1998; 105: 54S-58S.
  • 365. Abu-Judeh HH, Levine S, Kumar M, et al. Comparison of SPET brain perfusion and 18F-FDG brain metabolism in patients with chronic fatigue syndrome. Nucl Med Commun 1998; 19: 1056-1071.
  • 366. Cook DB, Lange G, DeLuca J, et al. Relationship of brain MRI abnormalities and physical functional status in chronic fatigue syndrome. Int J Neuroscience 2001; 107: 1-6.
  • 367. Saggini R, Pizzigallo E, Vecchiet J, et al. Alteration of spatial-temporal parameters of gait in chronic fatigue syndrome patients. J Neurol Sci 1998; 154: 18-25.
  • 368. Gordon R, Michalewski HJ, Nguyen T, et al. Cortical motor potential alterations in chronic fatigue syndrome. Int J Molec Med 1999; 4: 493-499.
  • 369. Johnson SK, DeLuca J, Diamond BJ, Natelson BH. Selective impairment of auditory processing in chronic fatigue syndrome: a comparison with multiple sclerosis and healthy controls. Percept Motor Skills 1996; 83: 51-62.
  • 370. Marcel B, Komaroff AL, Fagioli LR, et al. Cognitive deficits in patients with chronic fatigue syndrome. Biol Psychiatry 1996; 40: 535-541.
  • 371. Marshall PS, Watson D, Steinberg P, et al. An assessment of cognitive function and mood in chronic fatigue syndrome. Biol Psychiatry 1996; 39: 199-206.
  • 372. Marshall PS, Forstot M, Callies A, et al. Cognitive slowing and working memory difficulties in chronic fatigue syndrome. Psychosom Med 1997; 59: 58-66.
  • 373. Michiels V, Cluydts R, Fischler B, et al. Cognitive functioning in patients with chronic fatigue syndrome. J Clin Exp Neuropsychol 1996; 18: 666-677.
  • 374. Moss-Morris R, Petrie KJ, Large RG, Kydd RR. Neuropsychological deficits in chronic fatigue syndrome: artifact or reality? J Neurol Neurosurg Psychiatry 1996; 60: 474-477.
  • 375. Wearden AJ, Appleby L. Research on cognitive complaints and cognitive functioning in patients with chronic fatigue syndrome (CFS) - what conclusions can we draw? J Psychosom Res 1996; 41: 197-211.
  • 376. Kane RL, Gantz NM, Dipino RK. Neuropsychological and psychological functioning in chronic fatigue syndrome. Neuropsychiatr Neuropsychol Behav Neurol 1997; 10: 25-31.
  • 377. Landro NI, Stiles TC, Sletvold H. Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 1997; 42: 297-306.
  • 378. Vollmer-Conna U, Wakefield D, Lloyd A, et al. Cognitive deficits in patients suffering from chronic fatigue syndrome, acute infective illness or depression. Br J Psychiatry 1997; 171: 377-381.
  • 379. LaManca JJ, Sisto SA, DeLuca J, et al. Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome. Am J Med 1998; 105: 59S-65S.
  • 380. Blackwood SK, MacHale SM, Power MJ, et al. Effects of exercise on cognitive and motor function in chronic fatigue syndrome and depression. J Neurol Neurosurg Psychiatry 1998; 65: 541-546.
  • 381. Michiels V, Cluydts R, Fischler B. Attention and verbal learning in patients with chronic fatigue syndrome. J Int Neuropsychol Soc 1998; 4: 456-466.
  • 382. Wearden A, Appleby L. Cognitive performance and complaints of cognitive impairment in chronic fatigue syndrome (CFS). Psychol Med 1997; 27: 81-90.
  • 383. Ross S, Fantie B, Straus SF, et al. Divided attention deficits in patients with chronic fatigue syndrome. Applied Neuropsychology 2001; 8: 4-11.
  • 384. Van der Werf SP, Prins JB, Jongen PJ, et al. Abnormal neuropsychological findings are not necessarily a sign of cerebral impairment: a matched comparison between chronic fatigue syndrome and multiple sclerosis. Neuropsychiatr Neuropsychol Behav Neurol 2000; 13: 199-203.
  • 385. Petrie K, Moss-Morriss R, Weinman J. The impact of catastrophic beliefs on functioning in chronic fatigue syndrome. J Psychosom Res 1995; 39: 31-37.
  • 386. Van Houdenhove B, Onghena P, Neerinckx E, Hellin J. Does high "action-proneness" make people more vulnerable to chronic fatigue syndrome? A controlled psychometric study. J Psychosom Res 1995; 39: 633-640.
  • 387. Magnusson AE, Nias DKB, White PD. Is perfectionism associated with fatigue? J Psychosom Res 1996; 41: 377-383.
  • 388. Blenkiron PMA, Edwards R, Lynch S. Associations between perfectionism, mood, and fatigue in chronic fatigue syndrome: a pilot study. J Nerv Ment Dis 1999; 187: 566-570.
  • 389. White C, Schweitzer R. The role of personality in the development and perpetuating of chronic fatigue syndrome. J Psychosom Res 2000; 48: 515-524.
  • 390. Van Houdenhove B, Neerinckx E, Onghena P, et al. Premorbid "overactive" lifestyle in chronic fatigue syndrome and fibromyalgia: an etiological factor of proof of good citizenship? J Psychosom Res 2001; 51: 571-576.
  • 391. Wood B, Wessely S. Personality and social attitudes in chronic fatigue syndrome. J Psychosom Res 1999; 47: 385-397.
  • 392. DiClementi JD, Schmaling KB, Jones JF. Information processing in chronic fatigue syndrome: a preliminary investigation of suggestibility. J Psychosom Res 2001; 51: 679-686.
  • 393. Taylor RR, Jason LA. Sexual abuse, physical abuse, chronic fatigue, and chronic fatigue syndrome: a community-based study. J Nerv Ment Dis 2001; 189: 709-715.
  • 394. Theorell T, Blomkvist V, Lindh G, Evengard B. Critical life events, infections, and symptoms during the year preceding chronic fatigue syndrome (CFS): an examination of CFS patients and subjects with a nonspecific life crisis. Psychosom Med 1999; 61: 304-310.
  • 395. Endicott NA. Chronic fatigue syndrome in psychiatric patients: lifetime and premorbid personal history of physical health. Psychosom Med 1998; 60: 744-751.
  • 396. Hickie I, Bennett B, Lloyd A, et al. Complex genetic and environmental relationships between psychological distress, fatigue and immune functioning: a twin study. Psychol Med 1999; 29: 269-277.
  • 397. Buchwald D, Herrell R, Ashton S, et al. A twin study of chronic fatigue. Psychosom Med 2001; 63: 936-943.
  • 398. Stokes MJ, Cooper RG, Edwards RHT. Normal muscle strength and fatiguability in patients with effort syndromes. BMJ 1988; 297: 1014-1017.
  • 399. Riley MS, O'Brien CJ, McCluskey DR, et al. Aerobic work capacity in patients with chronic fatigue syndrome. BMJ 1990; 301: 953-956.
  • 400. Lloyd AR, Gandevia SC, Hales JP. Muscle endurance, twitch properties, voluntary activation and perceived exertion in normal subjects and patients with chronic fatigue syndrome. Brain 1991; 114: 85-98.
  • 401. Edwards RHT, Gibson H, Clague JE, Helliwell T. Muscle histopathology and physiology in chronic fatigue syndrome. Ciba Found Symp 1993; 173: 102-117.
  • 402. Gibson H, Carroll N, Clague JE, Edwards RHT. Exercise performance and fatiguability in patients with chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1993; 993-998.
  • 403. McCully KK, Natelson BH, Lotti S, et al. Reduced oxidative muscle metabolism in chronic fatigue syndrome. Muscle Nerve 1996; 19: 621-625.
  • 404. Lane RJM, Barrett MC, Woodrow D, et al. Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome. J Neurol Neurosurg Psychiatry 1998; 64: 362-367.
  • 405. Chaudhuri A, Behan PO. Chronic fatigue syndrome is an acquired neurological channelopathy. Hum Psychopharmacol Clin Exp 1999; 14: 7-17.
  • 406. Chaudhuri A, Watson WS, Pearn J, et al. The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses 2000; 54: 59-63.
  • 407. Montague TJ, Marrie TJ, Klassen GA, et al. Cardiac function at rest and with exercise in the chronic fatigue syndrome. Chest 1989; 95: 779-784.
  • 408. Lerner AM, Lawrie C, Dworkin HS. Repetitively negative changing T waves at 24-h electrocardiographic monitors in patients with the chronic fatigue syndrome. Chest 1993; 104: 1417-1421.
  • 409. Lerner AM, Goldstein J, Chang C, et al. Cardiac involvement in patients with chronic fatigue syndrome as documented with holter and biopsy data in Birmingham, Michigan, 1991-1993. Infect Dis Clin Pract 1997; 6: 327-333.
  • 410. McGregor NR, Dunstan RH, Zerbes M, et al. Preliminary determination of a molecular basis to chronic fatigue syndrome. Biochem Mol Med 1996; 57: 73-80.
  • 411. McGregor NR, Dunstan RH, Zerbes M, et al. Preliminary determination of the association between symptom expression and urinary metabolites in subjects with chronic fatigue syndrome. Biochem Mol Med 1996; 58: 85-92.
  • 412. McGregor NR, Dunstan RH, Butt HL, et al. A preliminary assessment of the association of SCL-90-R psychological inventory responses with changes in urinary metabolites in patients with chronic fatigue syndrome. J Chronic Fatigue Syndr 1997; 3: 17-37.
  • 413. Kuratsune H, Yamaguti K, Takahashi M, et al. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis 1994; 18 Suppl 1: S62-S67.
  • 414. Burnet RB, Yeap BB, Chatterton BE, Gaffney RD. Chronic fatigue syndrome: is total body potassium important? Med J Aust 1996; 164: 384.
  • 415. Dunstan RH, Donohoe M, Taylor W, et al. A preliminary investigation of chlorinated hydrocarbons and chronic fatigue syndrome. Med J Aust 1995; 163: 294-297.
  • 416. Dunstan RH, Roberts TK, Donohoe M, et al. Bioaccumulated chlorinated hydrocarbons and red/white blood cell parameters. Biochem Mol Med 1996; 58: 77-84.
  • 417. Hoffman RE, Stehr-Gren PA, Webb KB, et al. Health effects of long-term exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. JAMA 1986; 255: 2031-2038.
  • 418. Orbaek P, Nise G. Neurasthenic complaints and psychometric function of toluene-exposed rotogravure printers. Am J Ind Med 1989; 16: 67-77.
  • 419. Behan PO. Chronic fatigue syndrome as a delayed reaction to chronic low-dose organophosphate exposure. J Nutr Med 1996; 6: 341-350.
  • 420. Solomon G. A clinical and laboratory profile of symptomatic women with silicone and breast implants. Semin Arthritis Rheum 1994; 24: 29-37.
  • 421. Vasey FB, Havice DL, Bocanegra TS, et al. Clinical findings in symptomatic women with silicone breast implants. Semin Arthritis Rheum 1994; 24: 22-28.
  • 422. Bridges AJ. Rheumatic disorders in patients with silicone implants: a critical review. J Biomater Sci Polymer Ed 1995; 7: 147-157.
  • 423. Gatenby PA. Silicone breast implants, where have we been and where are we now? Aust N Z J Med 1996; 26: 341-342.
  • 424. Pearn JH. Chronic ciguatera: one cause of the chronic fatigue syndrome. J Chronic Fatigue Syndr 1996; 2: 29-34.
  • 425. Pearn JH. Chronic fatigue syndrome: chronic ciguatera poisoning as a differential diagnosis. Med J Aust 1997; 166: 309-310.
  • 426. Merikangas K, Angst J. Neurasthenia in a longitudinal cohort study of young adults. Psychol Med 1994; 24: 1013-1024.
  • 427. Lloyd R, Hales JP, Gandevia SC. Muscle strength, endurance and recovery in the post-infection fatigue syndrome. J Neurol Neurosurg Psychiatry 1988; 51: 1316-1322.
  • 428. English TL. A piece of my mind. Skeptical of skeptics. JAMA 1991; 265: 964.
  • 429. Ellen SR, Norman TR, Burrows GD. Assessment of anxiety and depression in primary care. Med J Aust 1997; 167: 328-333.
  • 430. Goldberg D, Williams P. A user's guide to the general health questionnaire. Berkshire: NFER-Nelson, 1988.
  • 431. Hickie IB, Davenport TA, Hadzi-Pavlovic D, et al. SPHERE: A National Depression Project. Development of a simple screening tool for common mental disorders in general practice. Med J Aust 2001; 175 Suppl: S10-S17.
  • 432. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care - the PRIME-MD 1000 study. JAMA 1994; 272: 1749-1756.
  • 433. Parker G, Hadzi-Pavlovic D, Boyce P, et al. Classifying depression by mental state signs. Br J Psychiatry 1990; 157: 55-65.
  • 434. Parker G, Hadzi-Pavlovic D, Wilhelm K, et al. Defining melancholia: properties of a refined sign-based measure. Br J Psychiatry 1994; 164: 316-326.
  • 435. Rutz W, von Knorring L, Walinder J. Frequency of suicide on Gotland after systematic postgraduate education of general practitioners. Acta Psychiatr Scand 1989; 80: 151-154.
  • 436. Appleby L, Amos T, Doyle U, et al. General practitioners and young suicide: a preventative role for primary care. Br J Psychiatry 1996; 168: 330-333.
  • 437. Power K, Davies C, Swanson V, et al. Case-control study of GP attendance rates by suicide cases with or without a psychiatric history. Br J Gen Pract 1997; 47: 211-215.
  • 438. Moscicki EK. Identification of suicide risk factors using epidemiologic studies. Psychiatr Clin North Am 1997; 20: 499-518.
  • 439. Maris RW. Social and familial risk factors in suicide behaviour. Psychiatr Clin North Am 1997; 20: 519-550.
  • 440. Vercoulen JH, Hommes OR, Swanink CM, et al. The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects. Arch Neurol 1996; 53: 642-649.
  • 441. Schmaling KB, Smith WR, Buchwald DS. Significant other responses are associated with fatigue and functional status among patients with chronic fatigue syndrome. Psychosom Med 2000; 62: 444-450.
  • 442. Goodwin SS. Couples' perceptions of wives' CFS symptoms, symptom change, and impact on the marital relationship. Issues Mental Health Nursing 2000; 21: 347-363.
  • 443. Cordingley L, Wearden A, Appleby L, Fisher L. The family response questionnaire: a new scale to assess the responses of family members to people with chronic fatigue syndrome. J Psychosom Res 2001; 51: 417-424.
  • 444. Valdini A, Steinhardt S, Feldman E. Usefulness of a standard battery of laboratory tests in investigating chronic fatigue in adults. Fam Pract 1989; 6: 286-291.
  • 445. Lane TJ, Matthews DA, Manu P. The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci 1990; 299: 313-318.
  • 446. Buchwald D, Komaroff AL. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis 1991; 13: S12-S18.
  • 447. Bates DW, Buchwald D, Lee J, et al. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med 1995; 155: 97-103.
  • 448. A Report of the CFS/ME Working Group. Report to the Chief Medical Officer of an independent working group. London: Department of Health, 2001. <http://www.doh.gov.uk/cmo/cfsmereport/index.htm> (accessed 18 Jan 2002).
  • 449. Hickie I, Davenport T. A behavioural approach based on reconstructing the sleep-wake cycle. Cog Behav Pract 1999; 6: 442-450.
  • 450. Hickie IB, Wilson AJ, Wright JM, et al. A randomized double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry 2000; 61: 643-648.
  • 451. Cope H, David A, Pelosi A, Mann A. Predictors of chronic "post viral" fatigue. Lancet 1994; 344: 864-868.
  • 452. Frank JD. The placebo is psychotherapy. Behav Brain Sci 1983; 6: 291.
  • 453. Elkin I, Shea T, Watkins JT, et al. National Institute of Mental Health treatment of depression collaborative research program. Arch Gen Psychiatry 1989; 46: 971-982.
  • 454. Rowe KS. Double-blind randomized controlled trial to assess the efficacy of intravenous gammaglobulin for the management of chronic fatigue syndrome in adolescents. J Psychiatr Res 1997; 133-147.
  • 455. Vollmer-Conna U, Hickie I, Hadzi-Pavlovic D, et al. Intravenous immunoglobulin is ineffective in the treatment of patients with chronic fatigue syndrome. Am J Med 1997; 103: 38-43.
  • 456. Natelson BH, Cheu J, Hill N, et al. Single-blind, placebo phase-in trial of two escalating doses of selegiline in the chronic fatigue syndrome. Neuropsychobiology 1998; 37: 150-154.
  • 457. Vercoulen JHMM, Swanink CMA, Zitman FG, et al. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome. Lancet 1996; 347: 858-861.
  • 458. Goldenberg DL, Felson DT, Dinerman H. A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371-1377.
  • 459. Jaeschke R, Adachi J, Guyatt G, et al. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 1991; 18: 447-451.
  • 460. McKenzie R, O'Fallen A, Dale J, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA 1998; 280: 1061-1066.
  • 461. Cleare AJ, Heap E, Malhi GS, et al. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet 1999; 353: 455-458.
  • 462. McKenzie R, Reynolds JC, O'Fallon A, et al. Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial. J Rheumatol 2000; 27: 2222-2226.
  • 463. Peterson PK, Pheley A, Schroeppel J, et al. A preliminary placebo-controlled crossover trial of fludrocortisone for chronic fatigue syndrome. Arch Intern Med 1998; 158: 908-914.
  • 464. Rowe PC, Calkins, H, DeBusk K, et al. Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial. JAMA 2001; 285: 52-59.
  • 465. Sharpe M, Hawton K, Simkin S, et al. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ 1996; 312: 22-26.
  • 466. Sharpe M. Cognitive behavior therapy for chronic fatigue syndrome: efficacy and implications. Am J Med 1998; 105: 104S-109S.
  • 467. Clapp LL, Richardson MT, Smith JF, et al. Acute effects of thirty minutes of light-intensity exercise on patients with chronic fatigue syndrome. Phys Ther 1999; 79: 749-756.
  • 468. White PD. The role of physical inactivity in the chronic fatigue syndrome. J Psychosom Res 2000; 49: 283-284.
  • 469. Afari N, Schmaling KB, Herrell R, et al. Coping strategies in twins with chronic fatigue and chronic fatigue syndrome. J Psychosom Res 2000; 48: 547-554.
  • 470. Edwards R, Suresh R, Lynch S, et al. Illness perceptions and mood in chronic fatigue syndrome. J Psychosom Res 2001; 50: 65-68.
  • 471. Creswell C, Chalder T. Defensive coping styles in chronic fatigue syndrome. J Psychosom Res 2001; 51: 607-610.
  • 472. Deale A, Chalder T, Wessely S. Illness beliefs and treatment outcome in chronic fatigue syndrome. J Psychosom Res 1998; 45: 77-83.
  • 473. Roesch SC, Weiner B. A meta-analytic review of coping with illness: do causal attributions matter? J Psychosom Res 2001; 50: 205-219.
  • 474. Marlin RG, Anchel H, Gibson JC, et al. An evaluation of multidisciplinary intervention for chronic fatigue syndrome with long-term follow-up, and a comparison with untreated controls. Am J Med 1998; 105: 110S-114S.
  • 475. Deale A, Chalder T, Marks I, Wessely S. Cognitive behaviour therapy for chronic fatigue syndrome: a randomised controlled trial. Am J Psychiatry 1997; 408-414.
  • 476. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ 1997; 314: 1647-1652.
  • 477. Prins JB, Bleijenberg G, Bazelmans E, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomized controlled trial. Lancet 2001; 357: 841-847.
  • 478. Whiting P, Bagnall AM, Sowden AJ, et al. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA 2001; 286: 1360-1368.
  • 479. Sharpe M, Wessely S. Putting the rest cure to rest - again: rest has no place in treating chronic fatigue. BMJ 1998; 316: 796.
  • 480. Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful treatment needing more careful evaluation. Lancet 1999; 354: 1229-1233.
  • 481. Powell P, Bentall RP, Nye FJ, Edwards RH. Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. BMJ 2001; 322: 387-390.
  • 482. Coutts R, Weatherby R, Davie A. The use of a symptom "self-report" inventory to evaluate the acceptability and efficacy of a walking program for patients suffering with chronic fatigue syndrome. J Psychosom Res 2001; 51: 425-429.
  • 483. Hare DL, Bunker SJ. Cardiac rehabilitation and secondary prevention. Med J Aust 1999; 171: 433-439.
  • 484. Lloyd AR, Hickie I, Brockman A, et al. Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993; 94: 197-203.
  • 485. Friedberg F, Krupp LB. A comparison of cognitive behavioural treatment for chronic fatigue syndrome and primary depression. Clin Infect Dis 1994; 18 Suppl 1: S105-S110.
  • 486. Wearden AJ, Morris RK, Mullis R, et al. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome [published erratum appears in Br J Psychiatry 1998; 173: 89]. Br J Psychiatry 1998; 172: 485-490.
  • 487. Sharpley AL, Williamson DJ, Attenburrow MEJ, et al. The effect of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology Berl 1996; 126: 50-54.
  • 488. Stores G, Wiggs L. Sleep abnormalities demonstrated by home polysomnography in teenagers with chronic fatigue syndrome. J Psychosom Res 1998; 45: 85-91.
  • 489. Le Bon O, Hoffmann G, Murphy J, et al. How significant are primary sleep disorders and sleepiness in the chronic fatigue syndrome? Sleep Res Online 2000; 3: 43-48.
  • 490. Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA 1994; 272: 1926-1931.
  • 491. Begg C, Cho M, Eastwood S, Horton R, et al. Improving the quality of reporting of randomized controlled trials. JAMA 1996; 276: 637-639.
  • 492. Freiman JA, Chalmers TC, Smith H Jr, Kuebler RR. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: survey of 71 "negative" trials. N Engl J Med 1978; 299: 690-694.
  • 493. Sacks H, Chalmers TC, Smith H. Randomized versus historical controls for clinical trials. Am J Med 1982; 72: 233-240.
  • 494. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 122-124.
  • 495. Sackett D. Cochrane collaboration. BMJ 1994; 309: 1514-1515.
  • 496. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999; 99: 112-116.
  • 497. Dobbins JG, Randall B, Reyes M, et al. The prevalence of chronic fatiguing illnesses among adolescents in the United States. J Chronic Fatigue Syndr 1997; 3: 15-27.
  • 498. Rowe KS, Rowe KJ. Symptom patterns of children and adolescents with chronic fatigue syndrome. In: Singh NN, Ollendick T, Singh AN, editors. International perspectives on child and adolescent mental health. In press.
  • 499. Smith MS, Mitchell J, Corey L, et al. Chronic fatigue in adolescents. Pediatrics 1991; 88: 195-202.
  • 500. Bell DS, Bell KM, Cheney PR. Primary juvenile fibromyalgia syndrome and chronic fatigue syndrome in adolescents. Clin Infect Dis 1994; 18 Suppl 1: S21-S23.
  • 501. Bell DS. Diagnosis of chronic fatigue syndrome in children and adolescents: special considerations. J Chronic Fatigue Syndr 1995; 1: 9-33.
  • 502. Bell DS. Illness onset characteristics in children with CFS and idiopathic chronic fatigue. J Chronic Fatigue Syndr 1997; 3: 43-51.
  • 503. Rowe KS, Fitzgerald P. Educational strategies for chronically ill students: chronic fatigue syndrome. Aust Educat Developmental Psychologist 1999; 16: 5-21.
  • 504. Rikard-Bell CJ, Waters BGH. Psychosocial management of chronic fatigue syndrome in adolescence. Aust N Z J Psych 1992; 26: 64-72.
  • 505. Carter BD, Kronenberger WG, Edwards JF, et al. Differential diagnosis of chronic fatigue in children: behavioral and emotional dimensions. J Dev Behav Pediatr 1996; 17: 16-21.
  • 506. Marcovitch H. Managing chronic fatigue syndrome in children: liaise with family and teachers to keep morale high and minimise disability. BMJ 1997; 314: 1635-1636.
  • 507. Wessely S. Diagnose and be damned: management of CFS in children is not contentious [letter]. BMJ 2000; 320: 1004.
  • 508. Lloyd AR. Chronic fatigue and chronic fatigue syndrome: shifting boundaries and attributions [review]. Am J Med 1998; 105: 7S-10S.
  • 509. Loblay RH. Chronic fatigue syndrome: what's in a name? Med J Aust 1995; 163: 285-286.
  • 510. Woodward RV, Broom DH, Legge DG. Diagnosis in chronic illness: enabling or disabling - the case of chronic fatigue syndrome. J R Soc Med 1995; 88: 325-329.
  • 511. Broom DH, Woodward R. Medicalisation reconsidered: toward a collaborative approach to care. Soc Health Illness 1996; 18: 357-378.
  • 512. Mechanic D. Illness behaviour: an overview. In: McHugh S, Vallis TM, editors. Illness behaviour: a multidisciplinary model. New York: Plenum, 1986: 101-109.
  • 513. Mechanic D. Chronic fatigue syndrome and the treatment process. Ciba Found Symp 1993; 173: 318-327.
  • 514. Finestone AJ. A doctor's dilemma: is a diagnosis disabling or enabling? Arch Intern Med 1997; 157: 491-492.
  • 515. Goldberg DP, Jenkins L, Millar T, Faragher EB. The ability of trainee general practitioners to identify psychological distress among their patients. Psychol Med 1993; 23: 185-193.
  • 516. Twemlow SW, Bradshaw SL, Coyne L, Lerma BH. Patterns of utilization of medical care and perceptions of the relationship between doctor and patient with chronic illness including chronic fatigue syndrome. Psychol Rep 1997; 80: 643-658.
  • 517. Ax S, Gregg VH, Jones D. Chronic fatigue syndrome: sufferers' evaluation of medical support. J R Soc Med 1997; 90: 250-254.
  • 518. Ware NC. Society, mind and body in chronic fatigue syndrome: an anthropological view. Ciba Found Symp 1993; 173: 62-73.
  • 519. Trimble MR. Functional diseases. BMJ 1982; 285: 1768-1770.
  • 520. Mayou R, Sharpe M. Diagnosis, disease and illness. QJM 1995; 88: 827-831.
  • 521. Jacobs G. Patient organisations are denied a voice [letter]. BMJ 1997; 315: 949.
  • 522. MacLean G, Wessely S. Professional and popular views of chronic fatigue syndrome. BMJ 1994; 308: 776-777.
  • 523. Shorte E. Chronic fatigue in historical perspective. Ciba Found Symp 1993; 173: 6-16.
  • 524. Ware NC. Sociosomatics and illness course in chronic fatigue syndrome. Psychosom Med 1998; 60: 394-401.
  • 525. Nisenbaum R, Jones A, Jones J, et al. Longitudinal analysis of symptoms reported by patients with chronic fatigue syndrome. Ann Epidemiol 2000; 10: 458.
  • 526. Fishbain DA. Secondary gain concept: definition problems and its abuse in medical practice. Am Pain Soc J 1994; 3: 264-273.
  • 527. Fishbain DA, Rosomoff HL, Cutler RB, Rosomoff RS. Secondary gain concept: a review of the scientific evidence. Clin J Pain 1995; 11: 6-21.
  • 528. Trigwell P, Hatcher S, Johnson M, Stanley P, House A. 'Abnormal' illness behaviour in chronic fatigue syndrome and multiple sclerosis. BMJ 1995; 311: 15-18.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article